| Entry |
|
|---|
| Name |
Nicotine;
(S)-3-(1-Methylpyrrolidin-2-yl)pyridine;
(S)-Nicotine;
3-[(S)-1-Methylpyrrolidin-2-yl]pyridine
|
|---|
| Formula |
C10H14N2
|
|---|
| Exact mass |
162.1157
|
|---|
| Mol weight |
162.23
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00760 | Nicotinate and nicotinamide metabolism |
| map00960 | Tropane, piperidine and pyridine alkaloid biosynthesis |
| map00980 | Metabolism of xenobiotics by cytochrome P450 |
| map01064 | Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid |
| map01110 | Biosynthesis of secondary metabolites |
| map01120 | Microbial metabolism in diverse environments |
| map05207 | Chemical carcinogenesis - receptor activation |
|
|---|
| Module |
| M00810 | Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde |
|
|---|
| Network |
|
|---|
| Enzyme |
|
|---|
| Brite |
Phytochemical compounds [BR:br08003]
Alkaloids
Alkaloids derived from nicotinic acid
Pyridine alkaloids
C00745 Nicotine
Pesticides [BR:br08007]
Pesticides
Insecticides
Others
C00745 Nicotine
Natural toxins [BR:br08009]
Phytotoxins
Alkaloids
Others
C00745 Nicotine
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07B DRUGS USED IN ADDICTIVE DISORDERS
N07BA Drugs used in nicotine dependence
N07BA01 Nicotine
D03365 Nicotine (USP) <JP/US>
USP drug classification [BR:br08302]
Anti-Addiction/Substance Abuse Treatment Agents
Smoking Cessation Agents
Nicotine
D03365 Nicotine (USP)
Therapeutic category of drugs in Japan [BR:br08301]
7 Agents not mainly for therapeutic purpose
79 Other agents not mainly for therapeutic purpose
799 Miscellaneous
7990 Miscellaneous
D03365 Nicotine (USP)
Classification of Japanese OTC drugs [BR:br08313]
Stop smoking aid
77 Stop smoking aid
D03365 Nicotine (USP)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Designated second-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Second-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00994 Nicotine
D03365 Nicotine
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
DG00994 Nicotine
D03365 Nicotine
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Acetylcholine (nicotinic)
CHRN
D03365 Nicotine (USP) <JP/US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03365
Rx-to-OTC switch list in the USA [br08315.html]
D03365
Rx-to-OTC switch list in Japan [br08314.html]
D03365
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 12
1 C8x C 29.1900 -17.5700
2 C8x C 29.1900 -18.9700
3 N5x N 30.3800 -19.6700
4 C8x C 31.6400 -18.9700
5 C8y C 31.6400 -17.5700
6 C8x C 30.3800 -16.8700
7 C1y C 32.8300 -16.8700
8 C1x C 34.1600 -17.2200
9 C1x C 35.0000 -16.1000
10 C1x C 34.0900 -14.9800
11 N1y N 32.8300 -15.4700
12 C1a C 31.6400 -14.7000
BOND 13
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 5 1 #Up
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 7 11 1
13 11 12 1
|
|---|
